S&P 500   4,531.68 (-0.10%)
DOW   35,483.93 (-0.35%)
QQQ   375.53 (+0.15%)
AAPL   149.20 (-0.04%)
MSFT   308.49 (+0.35%)
FB   340.90 (+0.04%)
GOOGL   2,829.35 (-0.21%)
TSLA   888.65 (+2.64%)
AMZN   3,430.15 (+0.44%)
NVDA   224.36 (+1.51%)
BABA   177.12 (-0.03%)
NIO   39.93 (+0.38%)
CGC   14.23 (+0.85%)
GE   103.62 (-2.25%)
AMD   118.18 (+1.54%)
MU   67.77 (-0.73%)
T   25.79 (-0.46%)
F   16.27 (+1.43%)
ACB   7.56 (-1.31%)
DIS   170.73 (+0.11%)
PFE   42.61 (-0.44%)
BA   214.55 (-0.75%)
AMC   40.81 (-0.17%)
S&P 500   4,531.68 (-0.10%)
DOW   35,483.93 (-0.35%)
QQQ   375.53 (+0.15%)
AAPL   149.20 (-0.04%)
MSFT   308.49 (+0.35%)
FB   340.90 (+0.04%)
GOOGL   2,829.35 (-0.21%)
TSLA   888.65 (+2.64%)
AMZN   3,430.15 (+0.44%)
NVDA   224.36 (+1.51%)
BABA   177.12 (-0.03%)
NIO   39.93 (+0.38%)
CGC   14.23 (+0.85%)
GE   103.62 (-2.25%)
AMD   118.18 (+1.54%)
MU   67.77 (-0.73%)
T   25.79 (-0.46%)
F   16.27 (+1.43%)
ACB   7.56 (-1.31%)
DIS   170.73 (+0.11%)
PFE   42.61 (-0.44%)
BA   214.55 (-0.75%)
AMC   40.81 (-0.17%)
S&P 500   4,531.68 (-0.10%)
DOW   35,483.93 (-0.35%)
QQQ   375.53 (+0.15%)
AAPL   149.20 (-0.04%)
MSFT   308.49 (+0.35%)
FB   340.90 (+0.04%)
GOOGL   2,829.35 (-0.21%)
TSLA   888.65 (+2.64%)
AMZN   3,430.15 (+0.44%)
NVDA   224.36 (+1.51%)
BABA   177.12 (-0.03%)
NIO   39.93 (+0.38%)
CGC   14.23 (+0.85%)
GE   103.62 (-2.25%)
AMD   118.18 (+1.54%)
MU   67.77 (-0.73%)
T   25.79 (-0.46%)
F   16.27 (+1.43%)
ACB   7.56 (-1.31%)
DIS   170.73 (+0.11%)
PFE   42.61 (-0.44%)
BA   214.55 (-0.75%)
AMC   40.81 (-0.17%)
S&P 500   4,531.68 (-0.10%)
DOW   35,483.93 (-0.35%)
QQQ   375.53 (+0.15%)
AAPL   149.20 (-0.04%)
MSFT   308.49 (+0.35%)
FB   340.90 (+0.04%)
GOOGL   2,829.35 (-0.21%)
TSLA   888.65 (+2.64%)
AMZN   3,430.15 (+0.44%)
NVDA   224.36 (+1.51%)
BABA   177.12 (-0.03%)
NIO   39.93 (+0.38%)
CGC   14.23 (+0.85%)
GE   103.62 (-2.25%)
AMD   118.18 (+1.54%)
MU   67.77 (-0.73%)
T   25.79 (-0.46%)
F   16.27 (+1.43%)
ACB   7.56 (-1.31%)
DIS   170.73 (+0.11%)
PFE   42.61 (-0.44%)
BA   214.55 (-0.75%)
AMC   40.81 (-0.17%)
BATS:VXZB

iPath Series B S&P 500 VIX Mid-Term Futures ETN Stock Forecast, Price & News

$25.54
-0.17 (-0.66 %)
(As of 10/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.52
▼
$25.75
50-Day Range
$25.31
▼
$27.58
52-Week Range N/A
Volume16,289 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive VXZB News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B S&P 500 VIX Mid-Term Futures ETN and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Barclays Capital
Fund NameiPath Series B S&P 500 VIX Mid-Term Futures ETN
Tax ClassificationExchange-Traded Note
SymbolBATS:VXZB
Inception Date1/17/2018
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset ClassMulti Asset
BenchmarkS&P 500 VIX Mid-Term Futures Index Total Return
CategoryAbsolute Returns
FocusVolatility
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$0.00
Average Daily Volume$20,335.60
Discount/Premium0.00%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.89%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market MakerVirtu Financial













iPath Series B S&P 500 VIX Mid-Term Futures ETN (BATS:VXZB) Frequently Asked Questions

What stocks does MarketBeat like better than iPath Series B S&P 500 VIX Mid-Term Futures ETN?

Wall Street analysts have given iPath Series B S&P 500 VIX Mid-Term Futures ETN a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iPath Series B S&P 500 VIX Mid-Term Futures ETN wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock price been impacted by Coronavirus?

iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock was trading at $25.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VXZB shares have increased by 1.5% and is now trading at $25.54.
View which stocks have been most impacted by COVID-19.

Who are some of iPath Series B S&P 500 VIX Mid-Term Futures ETN's key competitors?

Some companies that are related to iPath Series B S&P 500 VIX Mid-Term Futures ETN include 578896 (INB.L) (INB), Aberdeen Global Dynamic Dividend Fund (AGD), Aberdeen Income Credit Strategies Fund (ACP), Aberdeen International (AABVF), Aberdeen Total Dynamic Dividend Fund (AOD), AllianceBernstein National Municipal Income Fund (AFB), AllianzGI Convertible & Income 2024 Target Term Fund (CBH), Alternative Asset Opportunities PCC (TLI), Apollo Tactical Income Fund (AIF), Aptus Behavioral Momentum ETF (BEMO), Aptus Fortified Value ETF (FTVA), Ares Dynamic Credit Allocation Fund (ARDC), Bernstein Global Research Fund (BRGL), Bernstein U.S. Research Fund (BERN) and BlackRock 2022 Global Income Opportunity Trust (BGIO).
View all of VXZB's competitors.

What is iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock symbol?

iPath Series B S&P 500 VIX Mid-Term Futures ETN trades on the BATS under the ticker symbol "VXZB."

How do I buy shares of iPath Series B S&P 500 VIX Mid-Term Futures ETN?

Shares of VXZB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock price today?

One share of VXZB stock can currently be purchased for approximately $25.54.


This page was last updated on 10/21/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.